Evidence library

Ardorline sources

These are the primary, regulatory, guideline, and research-index sources used to ground the current public guide. They are starting points, not personal medical advice.

  1. FDA prescribing information: Vyleesi (bremelanotide)FDA-approved labelingOpen source →
  2. FDA: bulk substances that may present significant safety risksRegulatory sourceOpen source →

Review status

Last source review: August 24, 2026. No named clinician review is claimed. Corrections: editorial@formblends.com.